LekoskopLekoskop
UK · ES · FR · CS · IT · NL · CH · HR · PL

Drug Safety Update — United Kingdom — January 2026

MHRA medicines recalls and defect notifications with batch numbers, Serious Shortage Protocols, new approvals and Drug Safety Update — updated daily, automatically. Last updated: 27 Sep 2026 13:39.

All Recalls and defects2 Serious shortages (SSP)2 New approvals1 Drug Safety Update1
clear

Sources: we track changes based on information published by the MHRA — medicines recalls and defect notifications, Drug Safety Update and approval announcements — and the Serious Shortage Protocols published by the NHS Business Services Authority. The UK is outside the EU, so European Commission decisions are not listed here.

29 Jan 2026Thursday 29 January 2026

open day ◀ ▶ 1 event · 1 important
Drug Safety Update GLP
The product information for all Glucagon-Like Peptide-1 (GLP-1) receptor agonists and dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists has been further updated to highli…
What this means, batches, details

Loading…

22 Jan 2026Thursday 22 January 2026

open day ◀ ▶ 1 event · 1 important
Drug Safety Update Isotretinoin
The Commission on Human Medicines (CHM) has endorsed changes to the risk minimisation measures for isotretinoin, following a review of the impact of the measures implemented in 2023. We ask healthcare…
What this means, batches, details

Loading…

8 Jan 2026Thursday 8 January 2026

open day ◀ ▶ 1 event · 1 important
The MHRA has reviewed the warnings regarding addiction, dependence, withdrawal, and tolerance for gabapentin, pregabalin, benzodiazepines, and z-drugs. The findings (detailed in the Public Assessment…
What this means, batches, details

Loading…

In total 3 events in this category.